| Foot Specialists Of Tyler, Pa | |
|
649 S Broadway Ave, Suite 2, Tyler, TX 75701-1602 | |
| (903) 592-7200 | |
| (903) 592-7211 |
| Full Name | Foot Specialists Of Tyler, Pa |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 649 S Broadway Ave, Tyler, Texas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568504371 | NPI | - | NPPES |
| DF6646 | Other | TX | MEDICARE RAILROAD |
| 186188201 | Medicaid | TX | |
| 0013PD | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 1375 (Texas) | Primary |
| 332B00000X | Durable Medical Equipment & Medical Supplies | (* (Not Available)) | Secondary |
| Provider Name | Charles D Rhodus |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1962495341 PECOS PAC ID: 1153428495 Enrollment ID: I20070521000352 |
News Archive
Affymetrix, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID)-supported Pathogen Functional Genomics Resource Center (PFGRC) at the J. Craig Venter Institute (JCVI) today announced the launch of the Affymetrix FDA-ECSG custom microarray for identifying and discriminating between different strains of E. coli and Shigella.
CardioNet, Inc. announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 ("Biological Signal Management") to CardioNet. The patent includes certain systems and techniques utilized by the Company's Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex physiological information to make it useful for clinical decisions.
Children with hip and thigh implants designed to help heal a broken bone or correct other bone conditions are at risk for subsequent fractures of the very bones that the implants were intended to treat, according to new research from Johns Hopkins Children's Center.
Without access to soap and clean water, more than 2 billion people in low- and middle-income nations - a quarter of the world's population - have a greater likelihood of acquiring and transmitting the coronavirus than those in wealthy countries.
AstraZeneca and Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) recommends the investigational medicine metreleptin for the treatment of pediatric and adult patients with generalized lipodystrophy (LD).
› Verified 7 days ago
| Provider Name | Matthew O Kindle |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1891920583 PECOS PAC ID: 4486801883 Enrollment ID: I20120820000768 |
News Archive
Affymetrix, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID)-supported Pathogen Functional Genomics Resource Center (PFGRC) at the J. Craig Venter Institute (JCVI) today announced the launch of the Affymetrix FDA-ECSG custom microarray for identifying and discriminating between different strains of E. coli and Shigella.
CardioNet, Inc. announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 ("Biological Signal Management") to CardioNet. The patent includes certain systems and techniques utilized by the Company's Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex physiological information to make it useful for clinical decisions.
Children with hip and thigh implants designed to help heal a broken bone or correct other bone conditions are at risk for subsequent fractures of the very bones that the implants were intended to treat, according to new research from Johns Hopkins Children's Center.
Without access to soap and clean water, more than 2 billion people in low- and middle-income nations - a quarter of the world's population - have a greater likelihood of acquiring and transmitting the coronavirus than those in wealthy countries.
AstraZeneca and Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) recommends the investigational medicine metreleptin for the treatment of pediatric and adult patients with generalized lipodystrophy (LD).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Foot Specialists Of Tyler, Pa 649 S Broadway Ave, Suite 2, Tyler, TX 75701-1602 Ph: (903) 592-7200 | Foot Specialists Of Tyler, Pa 649 S Broadway Ave, Suite 2, Tyler, TX 75701-1602 Ph: (903) 592-7200 |
News Archive
Affymetrix, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID)-supported Pathogen Functional Genomics Resource Center (PFGRC) at the J. Craig Venter Institute (JCVI) today announced the launch of the Affymetrix FDA-ECSG custom microarray for identifying and discriminating between different strains of E. coli and Shigella.
CardioNet, Inc. announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 ("Biological Signal Management") to CardioNet. The patent includes certain systems and techniques utilized by the Company's Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex physiological information to make it useful for clinical decisions.
Children with hip and thigh implants designed to help heal a broken bone or correct other bone conditions are at risk for subsequent fractures of the very bones that the implants were intended to treat, according to new research from Johns Hopkins Children's Center.
Without access to soap and clean water, more than 2 billion people in low- and middle-income nations - a quarter of the world's population - have a greater likelihood of acquiring and transmitting the coronavirus than those in wealthy countries.
AstraZeneca and Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) recommends the investigational medicine metreleptin for the treatment of pediatric and adult patients with generalized lipodystrophy (LD).
› Verified 7 days ago
David A. Andreone, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 11937 Us Highway 271, Tyler, TX 75708 Phone: 903-877-7826 | |
Keith Robert Crandall, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1605 Stafford Dr, Tyler, TX 75703 Phone: 903-941-9247 Fax: 888-503-2519 | |
Thomas F Mccloskey Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1318 Clinic Dr, Tyler, TX 75701 Phone: 903-597-9622 Fax: 903-597-1210 | |
Foot Clinic Of East Texas Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 1828 Ese Loop323 Ste 111, Tyler, TX 75701 Phone: 903-593-0987 Fax: 903-592-3309 | |
Dr. Brandon E. Crim, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 417 S Saunders Ave, Tyler, TX 75702 Phone: 903-596-9173 | |
David A. Andreone Dpm Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 921 Shiloh Road, Ste C110, Tyler, TX 75703 Phone: 903-595-2858 Fax: 903-595-6970 | |
East Texas Podiatry Associates, P.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1028 E Idel, Suite A, Tyler, TX 75701 Phone: 903-593-1749 Fax: 903-593-1487 |